The upregulation of MEG3 contributes to decreased amyloid plaque deposition, the inhibition of oxidative stress and inflammatory injury and the amelioration of the cognitive impairment in AD rats (Yi et al., 2019). Here, MEG3 is linked to Alzheimer disease.